The dosimetric impact of control point spacing for sliding gap MLC fields.

Dynamic sliding gap multileaf collimator (MLC) fields are used to model MLC properties within the treatment planning system (TPS) for dynamic treatments. One of the key MLC properties in the Eclipse TPS is the dosimetric leaf gap (DLG) and precise determination of this parameter is paramount to ensuring accurate dose delivery. In this investigation, we report on how the spacing between control points (CPs) for sliding gap fields impacts the dose delivery, MLC positioning accuracy, and measurement of the DLG. The central axis dose was measured for sliding gap MLC fields with gap widths ranging from 2 to 40 mm. It was found that for deliveries containing two CPs, the central axis dose was underestimated by the TPS for all gap widths, with the maximum difference being 8% for a 2 mm gap field. For the same sliding gap fields containing 50 CPs, the measured dose was always within ± 2% of the TPS dose. By directly measuring the MLC trajectories we show that this dose difference is due to a systematic MLC gap error for fields containing two CPs, and that the cause of this error is due to the leaf position offset table which is incorrectly applied when the spacing between CPs is too large. This MLC gap error resulted in an increase in the measured DLG of 0.5 mm for both 6MV and 10 MV, when using fields with 2 CPs compared to 50 CPs. Furthermore, this change in DLG was shown to decrease the mean TPS-calculated dose to the target volume by 2.6% for a clinical IMRT test plan. This work has shown that systematic MLC positioning errors occur for sliding gap MLC fields containing two CPs and that using these fields to model critical TPS parameters, such as the DLG, may result in clinically significant systematic dose calculation errors during subsequent dynamic MLC treatments.

Improving motion management in radiation therapy: findings from a workshop and survey in Australia and New Zealand.

Motion management has become an integral part of radiation therapy. Multiple approaches to motion management have been reported in the literature. To allow the sharing of experiences on current practice and emerging technology, the University of Sydney and the New South Wales/Australian Capital Territory branch of the Australasian College of Physical Scientists and Engineers in Medicine (ACPSEM) held a two-day motion management workshop. To inform the workshop program, participants were invited to complete a survey prior to the workshop on current use of motion management techniques and their opinion on the effectiveness of each approach. A post-workshop survey was also conducted, designed to capture changes in opinion as a result of workshop participation. The online workshop was the most well attended ever hosted by the ACPSEM, with over 300 participants and a response to the pre-workshop survey was received from at least 60% of the radiation therapy centres in Australia and New Zealand. Motion management is extensively used in the region with use of deep inspiration breath-hold (DIBH) reported by 98% of centres for left-sided breast treatments and 91% for at least some right-sided breast treatments. Surface guided radiation therapy (SGRT) was the most popular session at the workshop and survey results showed that the use of SGRT is likely to increase. The workshop provided an excellent opportunity for the exchange of knowledge and experience, with most survey respondents indicating that their participation would lead to improvements in the quality of delivery of treatments at their centres.

In vivo real-time dosimetric verification in high dose rate prostate brachytherapy.

PURPOSE: To evaluate the performance of a diode array in the routine verification of planned dose to points inside the rectum from prostate high dose rate (HDR) brachytherapy using a real-time planning system. METHODS: A dosimetric study involving 28 patients was undertaken where measured doses received during treatment were compared to those calculated by the treatment planning system (TPS). After the ultrasound imaging required for treatment planning had been recorded, the ultrasound probe was replaced with a geometric replica that contained an 8 mm diameter cylindrical cavity in which a PTW diode array type 9112 was placed. The replica probe was then positioned inside the rectum with the individual diode positions determined using fluoroscopy. Dose was then recorded during the patients' treatment and compared to associated coordinates in the planning system. RESULTS: Factors influencing diode response and experimental uncertainty were initially investigated to estimate the overall uncertainty involved in dose measurements, which was determined to be +/- 10%. Data was acquired for 28 patients' first fractions, 11 patients' second fractions, and 13 patients' third fractions with collection dependent upon circumstances. Deviations between the diode measurements and predicted values ranged from -42% to +35% with 71% of measurements experiencing less than a 10% deviation from the predicted values. If the +/- 10% measurement uncertainty was combined with a tolerated dose discrepancy of +/- 10% then over 95% of the diode results exhibited agreement with the calculated data to within +/- 20%. It must also be noted that when large dose discrepancies were apparent they did not necessarily occur for all five diodes in the one measurement. CONCLUSIONS: This technique provided a method that could be utilized to detect gross errors in dose delivery of a real-time prostate HDR plan. Limitations in the detection system used must be well understood if meaningful results are to be achieved.